The effectiveness of a mobile high-frequency chest wall oscillation (HFCWO) device for airway clearance.
cystic fibrosis (CF)
functional respiratory imaging (FRI)
high-frequency chest wall oscillation (HFCWO)
sputum production
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
20
09
2019
revised:
07
03
2020
accepted:
11
04
2020
pubmed:
23
4
2020
medline:
1
12
2020
entrez:
23
4
2020
Statut:
ppublish
Résumé
High-frequency chest wall oscillation (HFCWO) is a commonly prescribed airway clearance technique (ACT) for patients whose ability to expectorate sputum is compromised. This study aimed to assess the effectiveness of a newly developed mobile ACT device (mHFCWO-The Monarch Airway Clearance System) in patients with cystic fibrosis (CF). A standard nonmobile HFCWO device (sHFCWO) was used as a comparator. This was a randomized, open-label, crossover pilot study. CF patients were treated with each device. Sputum was collected during and after each therapy session, while spirometry tests, Brody score assessment and functional respiratory imaging were performed before and after treatments. Wet weight of sputum collected during and after treatment was similar for mHFCWO and sHFCWO (6.53 ± 8.55 vs 5.80 ± 5.82; P = .777). Interestingly, the mHFCWO treatment led to a significant decrease in specific airway volume (9.55 ± 9.96 vs 8.74 ± 9.70 mL/L; P < .001), while increasing specific airway resistance (0.10 ± 0.16 vs 0.16 ± 0.23 KPA*S; P < .001). These changes were heterogeneously-distributed throughout the lung tissue and were greater in the distal areas, suggesting a shift of mucus. Changes were accompanied by an overall improvement in the Brody index (57.71 ± 16.55 vs 55.20 ± 16.98; P = .001). The newly developed mobile device provides airway clearance for CF patients comparable to a nonmobile sHFCWO device, yielding a change in airway geometry and patency by the shift of mucus from the more peripheral regions to the central airways.
Identifiants
pubmed: 32320537
doi: 10.1002/ppul.24784
pmc: PMC7496233
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1984-1992Informations de copyright
© 2020 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.
Références
Biorheology. 1994 Sep-Oct;31(5):511-20
pubmed: 7833454
Lancet. 2016 Nov 19;388(10059):2519-2531
pubmed: 27140670
Respir Care. 2009 Apr;54(4):522-37
pubmed: 19327189
Respir Care. 2013 Oct;58(10):1669-78
pubmed: 24064626
Expert Rev Respir Med. 2013 Dec;7(6):673-85
pubmed: 24224510
Physiother Can. 2015 Fall;67(4):319-26
pubmed: 27504031
Respir Care. 2010 Jun;55(6):695-701
pubmed: 20507651
J Appl Physiol (1985). 1988 Sep;65(3):1203-9
pubmed: 3182490
Radiology. 2010 Dec;257(3):854-62
pubmed: 21084417
Respir Care. 2012 Aug;57(8):1278-84
pubmed: 22348602
Biomed Instrum Technol. 1990 Jul-Aug;24(4):289-94
pubmed: 2390665
Respir Care. 2014 Oct;59(10):1537-41
pubmed: 24847094
Int J Nurs Stud. 2018 Dec;88:165-166
pubmed: 29506758
Thorax. 2010 Mar;65(3):196-200
pubmed: 19703826
Pediatr Pulmonol. 1996 Oct;22(4):271-4
pubmed: 8905888
J Thorac Imaging. 2006 Mar;21(1):14-21
pubmed: 16538150
Am J Respir Crit Care Med. 1994 Oct;150(4):1154-7
pubmed: 7921452
Chest. 1995 Oct;108(4):952-4
pubmed: 7555167
PLoS One. 2017 Dec 7;12(12):e0187483
pubmed: 29216201
Pediatr Pulmonol. 2020 Aug;55(8):1984-1992
pubmed: 32320537
Am Rev Respir Dis. 1983 Sep;128(3):511-5
pubmed: 6614645
Int J Chron Obstruct Pulmon Dis. 2012;7:667-71
pubmed: 23055715
Expert Rev Respir Med. 2016 Feb;10(2):193-206
pubmed: 26731531